The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
Cells · 05.07.2023 · 12 (13) · 1783
DOI: 10.3390/cells12131783 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 05.07.2023. Verfasst von Adrian Vasile Dumitru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Hodgkin Disease, Lymphoma, Lymphoma, Large-Cell, Anaplastic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
CD30, also known as TNFRSF8 (tumor necrosis factor receptor superfamily member 8), is a protein receptor that is heavily glycosylated inside the Golgi apparatus, as well as a tumor marker that is found on the surface of specific cells in the body, including certain immune cells and cancer ones. This review aims to shed light on the critical importance of CD30, from its emergence in the cell to its position in diagnosing various diseases, including Hodgkin lymphoma, where it is expressed on Hodgkin and Reed–Sternberg cells, as well as embryonal carcinoma, anaplastic large cell lymphoma (ALCL), and cutaneous T-cell lymphoma (CTCL). In addition to its role in positive diagnosis, targeting CD30 has been a promising approach treating CD30-positive lymphomas, and there is ongoing research into the potential use of CD30-targeted therapies for autoimmune disorders. We aim to elaborate on CD30’s roles as a tumor marker, supporting thus the hypothesis that this receptor might be the aim of cytostatic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Pathology, University Emergency Hospital, 050098 Bucharest, Romania.
- Department of Pathology, Colțea Clinical Hospital, 030171 Bucharest, Romania.
- Department of Anatomy, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Obstetrics and Gynecology, University Emergency Hospital, 050098 Bucharest, Romania.
- Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
ORCID-Profile: Dana Antonia Țăpoi, David-Ioan Dumitrascu, Mihail Constantin Ceaușu
Zitieren
APA
Dumitru, A. V., Țăpoi, D. A., Halcu, G., Munteanu, O., Dumitrascu, D. I., Ceaușu, M. C., & Gheorghișan-Gălățeanu, A. A. (2023). The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment. Cells, 12(13), 1783. https://doi.org/10.3390/cells12131783
Vancouver
Dumitru AV, Țăpoi DA, Halcu G, Munteanu O, Dumitrascu DI, Ceaușu MC, et al. The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment. Cells. 2023;12(13):1783. doi:10.3390/cells12131783
BibTeX
@article{Dumitru2023,
author = {Dumitru, Adrian Vasile and Țăpoi, Dana Antonia and Halcu, Georgian and Munteanu, Octavian and Dumitrascu, David-Ioan and Ceaușu, Mihail Constantin and Gheorghișan-Gălățeanu, Ancuța-Augustina},
title = {The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment},
journal = {Cells},
year = {2023},
volume = {12},
number = {13},
pages = {1783},
doi = {10.3390/cells12131783}
}
EUVIMED